Aravive, Inc. Gains 30.53%

Tue, Nov 01, 2022 at 07:27 PM
Aravive, Inc. Gains 30.53%

Aravive, Inc. (ARAV:NASDAQ) shot up at $1.71, representing a gain of 30.5%. On Tue, Nov 01, 2022, ARAV:NASDAQ hit a New 2-Week High of $1.71. The stock got featured on our News Catalysts scanner on Tue, Oct 25, 2022 at 09:12 AM in the 'PRIVATE PLACEMENT' category. From Tue, Oct 18, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.